SquamousCellCarcinomaofSkin near Winter Haven, FL

Care Philosophy: Dr Peguero received his MD from Ponce School of Medicine, Puerto Rico. He completed a neurology residency at the University of South Florida, Morsani College of Medicine. After completing his residency, Dr Peguero completed a fellowship in epilepsy and EEG at Vanderbilt University School of Medicine. After his fellowship, Dr Peguero was employed at The Watson Clinic, Department of Neurology, Lakeland, Florida, where he also served as Chief of Service of Neurology at Lakeland Regional Medical Center. Dr Peguero was an Assistant Professor at Ponce School of Medicine, and most recently, he has worked in private practice. Dr Peguero's clinical interest is in General Neurology, Epilepsy and Clinical Neurophysiology.

Care Philosophy: Dr Isenalumehe earned her MD from Sophie Davis School of Biomedical Education, CUNY Medical College, City College of New York (BA/MD Program) / Albany Medical College, New York and her MS degree in Clinical and Biomedical Investigation from the University of Southern California, Los Angeles. She completed a combined Internal Medicine and Pediatric Residency at NJMS-Rutgers (former: University of Medicine and Dentistry of New Jersey, Newark, where she also served as Internal Medicine-Pediatrics Chief Resident. She completed a Pediatric Hematology-Oncology Fellowship at Children's Hospital of Los Angeles, University of Southern California, where she also served as Chief Fellow.

Care Philosophy: Dr Blue earned his MD at Meharry Medical College, Nashville, Tennessee. Dr Blue completed an Internal Medicine Residency in the Department of Medicine at Washington University School of Medicine, St. Louis, Missouri, and d a Hematology/Oncology Fellowship in the Department of Medicine at Saint Louis University School of Medicine. Dr Blue recently completed a Blood and Marrow Transplant and Cellular Immunotherapy Fellowship at Moffitt Cancer Center. Dr Blue's clinical interests include treatment of plasma cell disorders and evaluation of patients pre and post bone marrow transplant. His research interests include reducing health disparities and improving health outcomes for plasma cell dyscrasias.

Care Philosophy: Dr Andre Beer Furlan is a skull base and endovascular neurosurgeon at Moffitt Cancer Center and Assistant Professor of Oncologic Sciences at the University of South Florida. Dr Beer Furlan earned his MD and PhD degrees from the University of Svo Paulo (FMUSP), a top ranked university in Latin America. He completed the neurosurgery residency at the same institution and practiced as a neurosurgeon and skull base surgeon in Sao Paulo, Brazil before moving to the United States.

Care Philosophy: Dr Sameh Gaballa is an AssociateMember in the Moffitt Cancer Center Department of Malignant Hematology. Dr Gaballa earned his MD from Aims Shams University in Cairo, Egypt. He completed an Internal Medicine Residency and a Hematology and Medical Oncology Fellowship at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. He then completed a Stem Cell Transplantation and Cellular Therapy Fellowship at the University of Texas MD Anderson Cancer Center. Dr Gaballa previously practiced in the Thomas Jefferson University, Division of Hematologic Malignancies and Blood and Marrow Transplantation.

Care Philosophy: Dr Chadha is an Assistant Professor at the University of South Florida, Morsani College of Medicine. After graduating from New York University, he completed his medical degree from the New York Institute of Technology College of Osteopathic Medicine and completed an Internal Medicine Residency at Icahn School of Medicine at Mount Sinai. Most recently, he completed a Hematology/Oncology Fellowship at the Donald and Barbara Zucker School of Medicine at Hofstra Northwell Health Lenox Hill Hospital. Dr Chadha's focus is solid tumor oncology, with clinical interests in genitourinary tract tumors, including prostate cancer, bladder cancer, kidney cancer, testicular cancer, and thoracic malignancies.

Care Philosophy: Dr. Fletcheris an Associate Professor of Medicine within the Division of Hematology and Oncology. He is a Veterans Administration Advanced Career Development Awardee, American Heart Association Career Development Awardee and Florida Biomedical Research Program NIR Awardee.

Care Philosophy: Dr Nam Tran is a neuro-oncology surgeon at Moffitt Cancer Center and assistant professor of oncology and neurosurgery at the University of South Florida College of Medicine. Dr Tran completed his fellowship training at Moffitt, following a residency in neurosurgery at Medical College of Virginia. He was chief resident his final year. Prior to that, he was affiliated for several years with the University of California-Irvine, where he received a Ph.D. in neuroscience and served as an assistant project scientist. Dr Tran's research interests include regulation of the blood brain barrier, tumor and trauma-associated cerebral edema, central nervous system malignancies and spine biomechanics.

Care Philosophy: Dr Hoffman is a gynecologic oncologist and Vice Chair for the Gynecologic Oncology Program at Moffitt Cancer Center. He is a world-renowned expert in the surgical management of gynecologic cancers and other complex gynecologic disorders. He has over 30 years of surgical experience, has published extensively on all aspects of female cancer surgery, and has lectured around the world on these subjects. Dr Hoffman's expertise includes laparoscopic, robotic, open (traditional), and vaginal surgery. After completing his gynecologic oncology fellowship at the University of South Florida, Dr Hoffman stayed as a full-time faculty member until October 2015.

Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patient's experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.

Care Philosophy: Dr Iman Imanirad is an Assistant Member at Moffitt Cancer Center. He is also a Professor of Oncology at the University of South Florida College of Medicine. Dr Imanirad received his medical degree from Saba University School of Medicine and completed his residency at the University of Florida where he also completed three years of hematology oncology fellowship. After completing his fellowship, he worked as a medical Oncologist and hematologist at Tallahassee Memorial Hospital to fulfill the requirements for a J1 visa. During his fellowship, Dr Imanirad was the recipient of several awards such as Most Outstanding Fellow Award and Fellow of the Year Award. He was also awarded the Moffitt High Performer Award in 2019.

Care Philosophy: Dr Tiago Biachi de Castria is an Associate Member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. Dr Biachi de Castria received his MD degree from Universidade Federal de Civ™ncias da Sav?de de Porto Alegre, Brazil. He also obtained a Doctorate degree in Internal Medicine and Therapeutics from Svo Paulo Federal University. He completed his Residency in Internal Medicine at Svo Paulo Federal University and his Clinical Oncology Fellowship at the Svo Paulo University - Svo Paulo Cancer Institute. Dr Biachi de Castria was an attending in the Gastrointestinal Oncology Service at the Svo Paulo Cancer Institute and Sv?rio-Libanv™s Hospital.

Biography: Dr. Sotomayor is the director of the newly established Cancer Institute at Tampa General Hospital. He is a pioneer in the field of cancer immunology and immunotherapy and an internationally renowned expert in lymphoma research and treatment. Prior to joining Tampa General, he was the director of the George Washington University Cancer Center with responsibility and authority over all aspects of cancer care and research at GW and affiliated health systems. He was also a professor of medicine in the division of hematology/oncology at George Washington University School of Medicine and Health Sciences. Fluent in English and Spanish, Dr. Sotomayor specializes in the treatment of lymphomas and leukemias. The accomplished physician-scientist's ongoing research is directed toward cancer immunology and immunotherapy with special focus in developing novel immune-based approaches for the treatment of lymphomas and other hematologic malignancies. Considered as a world expert in mantle cell lymphoma (MCL), he has more than 140 publications including seminal discoveries published in top tier journals such as Nature Immunology, Nature Medicine, Blood, Proceedings of the National Academy of Sciences, Cancer Cell among others. He has been the recipient of several awards, including the recipient of the National Cancer Institute (NCI) CURE Lifetime Achievement award in 2017. Dr. Sotomayor is involved in several major medical societies and organizations and currently is a member of the Scientific Advisory Board, Lymphoma Research Foundation, member of the Executive Committee of the Mantle Cell Lymphoma Consortium and member of several committees of the American Association for Cancer Research (AACR). He has also served in committees at the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO) and the National Cancer Institute (NCI)